Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented OrbiMed on the transaction. OrbiMed announced it has raised more than $4.3 billion in commitments for its latest private investment...
OrbiMed’s $4.3 Billion Funding Round
ABS Capital’s Closing of First Continuation Fund
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented ABS Capital in the deal. ABS Capital announced the closing of its first continuation fund, a GP-led secondary transaction...